Gilead Sciences, Inc. (GILD) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Gilead Sciences, Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.
GILD
Gilead Sciences, Inc.
$129.54HealthcareDelayed quote: Jul 30, 2026, 12:05 PM EDT
LLY
Eli Lilly and Company
$1,162.47HealthcareDelayed quote: Jul 30, 2026, 12:05 PM EDT
Total return — GILD vs LLY
growth of $100 · dividends reinvested · last 30yGILD +32914.4%LLY +9308.2%GILD compounded faster
GILD LLY
GILD vs LLY: by the numbers
- •LLY is the larger company ($1.09T vs $160.83B market cap).
- •GILD trades at the lower trailing earnings multiple (18.08 vs 42.98 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 30.99% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 3.07% CAGR).
- •GILD pays the higher dividend yield (2.43% vs 0.53%).
Metrics side by side
Valuation
| Metric | GILD | LLY |
|---|---|---|
| P/E ratio | 18.08 | 42.98 |
| Forward P/E | N/A | 34.45 |
| P/S ratio | 5.60 | 15.00 |
| P/B ratio | 7.08 | 34.75 |
| PEG ratio | 0.01 | 0.49 |
| EV / EBITDA | 12.81 | 32.30 |
| FCF yield | 6.15% | 1.25% |
Profitability
| Metric | GILD | LLY |
|---|---|---|
| Gross margin | 79.35% | 83.51% |
| Operating margin | 38.26% | 45.87% |
| Net margin | 30.99% | 34.98% |
| ROE | 39.19% | 81.01% |
| ROIC | 21.53% | 30.20% |
Dividends
| Metric | GILD | LLY |
|---|---|---|
| Dividend yield | 2.43% | 0.53% |
| Payout ratio | 47.08% | 28.09% |
Growth (annualized)
| Metric | GILD | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 3.07% | 23.17% |
| EPS CAGR (5Y) | 133.83% | 28.88% |
| FCF CAGR (5Y) | 3.30% | 19.54% |
| Total return CAGR (5Y) | 17.92% | 38.90% |
Frequently asked
- Which has the lower trailing P/E, GILD or LLY?
- GILD has the lower trailing P/E: GILD trades at 18.08 and LLY at 42.98. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, GILD or LLY?
- Over the past five years, LLY grew revenue faster — GILD at a 3.07% CAGR versus LLY at 23.17%.
- Does GILD or LLY pay a bigger dividend?
- GILD yields 2.43% and LLY yields 0.53% based on trailing dividends and the latest price.
- Is GILD or LLY more profitable?
- LLY runs the higher net margin — GILD at 30.99% versus LLY at 34.98%.
- How have GILD and LLY total returns compared?
- Over the past 10 years, GILD delivered 9.06% and LLY delivered 32.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gilead Sciences P/E ratioEli Lilly and P/E ratioGilead Sciences dividend yieldEli Lilly and dividend yieldGilead Sciences ROEEli Lilly and ROEGilead Sciences operating marginEli Lilly and operating marginGilead Sciences revenue growthEli Lilly and revenue growthGilead Sciences free cash flowEli Lilly and free cash flow
Gilead Sciences & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.